Managed Access Program for Momelotinib in Myelofibrosis
NCT05582083
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Myelofibrosis
Primary Myelofibrosis
Interventions
DRUG:
Momelotinib
Sponsor
GlaxoSmithKline